AU4393799A - Pharmaceutical composition containing an ester or amide pla2 inhibitor - Google Patents

Pharmaceutical composition containing an ester or amide pla2 inhibitor

Info

Publication number
AU4393799A
AU4393799A AU43937/99A AU4393799A AU4393799A AU 4393799 A AU4393799 A AU 4393799A AU 43937/99 A AU43937/99 A AU 43937/99A AU 4393799 A AU4393799 A AU 4393799A AU 4393799 A AU4393799 A AU 4393799A
Authority
AU
Australia
Prior art keywords
amide
ester
pharmaceutical composition
composition containing
pla2 inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43937/99A
Inventor
Rinta Ibuki
Saburo Murata
Norio Ohnishi
Fumio Shimojo
Satoshi Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU4393799A publication Critical patent/AU4393799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU43937/99A 1998-06-29 1999-06-25 Pharmaceutical composition containing an ester or amide pla2 inhibitor Abandoned AU4393799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18214398 1998-06-29
JP10/182143 1998-06-29
PCT/JP1999/003402 WO2000000220A1 (en) 1998-06-29 1999-06-25 Pharmaceutical composition containing an ester or amide pla2 inhibitor

Publications (1)

Publication Number Publication Date
AU4393799A true AU4393799A (en) 2000-01-17

Family

ID=16113116

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43937/99A Abandoned AU4393799A (en) 1998-06-29 1999-06-25 Pharmaceutical composition containing an ester or amide pla2 inhibitor

Country Status (5)

Country Link
EP (1) EP1091760A1 (en)
JP (1) JP2001501980A (en)
AR (1) AR019725A1 (en)
AU (1) AU4393799A (en)
WO (1) WO2000000220A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR529701A0 (en) * 2001-05-28 2001-06-21 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA199800155A1 (en) * 1995-07-24 1999-02-25 Фудзисава, Фармасьютикал Ко., Лтд NEW CONNECTION

Also Published As

Publication number Publication date
EP1091760A1 (en) 2001-04-18
JP2001501980A (en) 2001-02-13
WO2000000220A1 (en) 2000-01-06
AR019725A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
AU2584399A (en) Point of sale device
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
DK1105122T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LIPASE INHIBITORS
AU6477498A (en) Scale inhibitors
AU1339699A (en) Polyether ester amides
AU4699996A (en) Epoxy-cyanate ester compositions
AU5687396A (en) N-aroylamino acid amides as endothelin inhibitors
AU4231197A (en) Hppd gene and inhibitors
AU5386598A (en) Compositions containing hydroxy acids or retinoids
AU9537098A (en) 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein
AU1530001A (en) Inhibitor compositions
HUP9901984A3 (en) Naphthyl acetamides as spla2 inhibitors, use thereof and pharmaceutical compositions containing these compounds
AU3191599A (en) Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU5589298A (en) Phenyl acetamides as spla2 inhibitors
HUP9900911A3 (en) Esters and amides as pla2 inhibitors
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
AU4128597A (en) Phosphatidylcholine synthesis inhibitors
HUP0201636A1 (en) Indol derivative as spla2 inhibitor and pharmaceutical composition containing it
AU2089297A (en) Composition for prevention of hepatic steatosis
AU9640698A (en) Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate
AU8898198A (en) Methods of identifying biological agent compositions
AU1149797A (en) Naphthyl glyoxamides as spla2 inhibitors
AUPP076797A0 (en) Phospholipase inhibitor
AU2373600A (en) Novel spla2 inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase